These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 11351554)

  • 1. [Apolipoprotein A-II].
    Takata K
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():101-4. PubMed ID: 11351554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Apolipoprotein A-II abnormality].
    Takahashi S; Miyamori I
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):24-6. PubMed ID: 9644998
    [No Abstract]   [Full Text] [Related]  

  • 3. ApoAII controversy still in rabbit?
    Shimano H
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):1984-5. PubMed ID: 19923556
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of apolipoprotein A-II as a positional candidate gene for familial Type II diabetes, altered lipid concentrations, and insulin resistance.
    Elbein SC; Chu W; Ren Q; Wang H; Hemphill C; Hasstedt SJ
    Diabetologia; 2002 Jul; 45(7):1026-33. PubMed ID: 12136402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
    Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
    Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-II suppressed concanavalin A-induced hepatitis via the inhibition of CD4 T cell function.
    Yamashita J; Iwamura C; Sasaki T; Mitsumori K; Ohshima K; Hada K; Hara N; Takahashi M; Kaneshiro Y; Tanaka H; Kaneko K; Nakayama T
    J Immunol; 2011 Mar; 186(6):3410-20. PubMed ID: 21300819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apolipoprotein A-II].
    Takata K
    Nihon Rinsho; 1999 Sep; 57 Suppl():90-2. PubMed ID: 10543057
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipid-poor apolipoprotein A-I, glycated apolipoprotein A-I].
    Maeda S; Suzuki M; Seishima M
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():101-4. PubMed ID: 15658274
    [No Abstract]   [Full Text] [Related]  

  • 10. [Apoproteins in dyslipoproteinemia (author's transl)].
    Dewailly P
    Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of human apolipoprotein A-II in transgenic mice does not increase their susceptibility to insulin resistance and obesity.
    Escolà-Gil JC; Blanco-Vaca F; Julve J
    Diabetologia; 2002 Apr; 45(4):600-1. PubMed ID: 12032642
    [No Abstract]   [Full Text] [Related]  

  • 12. [From clinical tests to etiology: analysis of clinical features. Deficiency of apolipoproteins].
    Yamamura T; Yamamoto A
    Rinsho Byori; 1987 Dec; Spec No 75():93-108. PubMed ID: 3448286
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of intronic sequences in the transcriptional regulation of apolipoprotein B, E and A-II genes.
    Chartier FL; Bossu JP; Vu-Dac N; Fruchart JC; Laine B
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():44-5. PubMed ID: 8767458
    [No Abstract]   [Full Text] [Related]  

  • 14. Significant impact of the highly informative (CA)n repeat polymorphism of the APOA-II gene on the plasma APOA-II concentrations and HDL subfractions: The ECTIM study.
    Brousseau T; Dupuy-Gorce AM; Evans A; Arveiler D; Ruidavets JB; Haas B; Cambou JP; Luc G; Ducimetière P; Amouyel P; Helbecque N
    Am J Med Genet; 2002 Jun; 110(1):19-24. PubMed ID: 12116266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apolipoprotein A-I, A-II, A-IV].
    Kazumi T; Yoshino G
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():98-100. PubMed ID: 15658273
    [No Abstract]   [Full Text] [Related]  

  • 16. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
    Kontush A; de Faria EC; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Illegitimate expression of apolipoprotein A-II in Caco-2 cells is due to chromatin organization.
    Le Beyec J; Ribeiro A; Schreider C; Chambaz J; Rousset M; Pinçon-Raymond M; Cardot P
    Exp Cell Res; 1999 Mar; 247(2):373-9. PubMed ID: 10066365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference maps of mouse serum acute-phase proteins: changes with LPS-induced inflammation and apolipoprotein A-I and A-II transgenes.
    Wait R; Chiesa G; Parolini C; Miller I; Begum S; Brambilla D; Galluccio L; Ballerio R; Eberini I; Gianazza E
    Proteomics; 2005 Nov; 5(16):4245-53. PubMed ID: 16196095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Caucasian male with very low blood cholesterol and low apoA-II without evidence of atherosclerosis.
    Park SH; Kim JR; Park JE; Cho KH
    Eur J Clin Invest; 2007 Apr; 37(4):249-56. PubMed ID: 17373959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The apolipoprotein AII gene is not a risk factor for development ischemic heart disease in the Moscow population].
    Shadrina MI; Slominskiĭ PA; Perova NV; Limborskaia SA
    Genetika; 1997 Sep; 33(9):1316-8. PubMed ID: 9445826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.